C771g (His241Gln) polymorphism of MLXIPL Gene, TG levels and coronary artery disease: A case control study

Anadolu Kardiyoloji Dergisi

Volumn 15, Issue 1, 2015, Pages 8-12

  Ghasemi, Asghar ^a   Aghajani, Hasan ^a   Fallah, Soudabeh ^a   Assadi, Mehrdad ^a   Seifi, Morteza ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Coronary artery disease; MLXIPL; Polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; TRIACYLGLYCEROL; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; MLXIPL PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MLXIPL GENE; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; IRAN; MIDDLE AGED; RISK FACTOR; ALLELE; BODY MASS; CORONARY ANGIOGRAPHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; LIPID ANALYSIS; POPULATION GENETICS;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CORONARY STENOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 84921878392     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.5135     Document Type: Article

References (24)

1. Wang Q. Molecular genetics of coronary artery disease. Curr Opin Cardiol 2005; 20: 182-8. [CrossRef]
2. Topol EJ. The genomic basis of myocardial infarction. J Am Coll Cardiol 2005; 46: 1456-65. [CrossRef]
3. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, et al. Functional Genomics and Translational Biology Interdisciplinary Working Group: Relevance of genetics and genomics for preventionand treatment of cardiovascular disease: Circulation 2007; 115: 2878-901. [CrossRef]
4. Zintzaras E, Kitsios G. Identification of chromosomal regions linked to premature myocardial infarction: a meta-analysis of wholegenome searches. J Hum Genet 2006; 51: 1015-21. [CrossRef]
5. Damani SB, Topol EJ. Future use of genomics in coronary artery disease. J Am Coll Cardiol 2007; 50: 1933-40. [CrossRef]
6. Ordovas JM. HDL genetics, candidate genes, genome wide scans and gene-environment interactions. Cardiovasc Drugs Ther 2002; 16: 273-81. [CrossRef]
7. Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 2004; 5: 189-218. [CrossRef]
8. Ma L, Robinson LN, Towle HC. ChREBP Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem 2006; 39: 28721-30. [CrossRef]
9. Kooner JS, Chambers JC, Aguilar-Salinas CA, Hinds DA, Hyde CL, Warnes GR, et al. Genome-wide scan identiWes variation in MLXIPL associated with plasma triglycerides. Nat Genet 2008; 40: 149-51 [CrossRef]
10. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40: 189-97. [CrossRef]
11. Stoeckman AK, Ma L, Towle HC. Mlx Is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem 2004; 279: 15662-9. [CrossRef]
12. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 5: 5-40. [CrossRef]
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human ucleated cells. Nucleic Acid Res 1993; 16: 1215. [CrossRef]
14. Jiang CQ, Liu B, Cheung BMY, Lam TH, Lin JM, Jin YL, et al. A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese. Eur J Hum Genet 2010; 18: 1255-60. [CrossRef]
15. Vastermark A, Jacobsson JA, Johansson ASA, Fredriksson R, Gyllensten ULF2, Schioth H. Polymorphisms in sh2b1 and spns1 loci are associated with triglyceride levels in a healthy population in northern Sweden. J Genet 2012; 91: 237-40. [CrossRef]
16. Yamashita H, Takenoshita M, Sakurai M, Bruick, RK, Henzel WJ, Shillinglaw W, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 2001; 98: 9116-21. [CrossRef]
17. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA 2004; 101: 7281-6. [CrossRef]
18. Dentin R, Pegorier JP, Benhamed F, Foufelle F, Ferre P, Fauveau V, et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 2004; 279: 20314-26. [CrossRef]
19. Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci USA 2004; 101: 15597-602. [CrossRef]
20. Uyeda K, Repa JJ. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab 2006; 4: 107-10. [CrossRef]
21. Pan LA, Chen YC, Huang H, Zhang L, Liu R, Li X, et al. G771C polymorphism in the MLXIPL gene is associated with a risk of coronary artery disease in the Chinese: A case-control study. Cardiology 2009; 114: 174-8. [CrossRef]
22. Vrablik M, Ceska R, Adamkova V, Peasey A, Pikhart H, Kubinova R, et al. MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe. Hum Genet 2008; 124: 553-5. [CrossRef]
23. Guo S, Zheng F, Qiu X, Yang N. ChREBP gene polymorphisms are associated with coronary artery disease in Han population of Hubei province. Clinica Chimica Acta 2011; 412: 1854-60. [CrossRef]
24. Assmann G, Schulte H, Funke H, von Eckardstein A. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 1998; 19: 8-14.